Skip to main content

NY Judges Favors Defendant Over Design Defect Claim

NY Judges Favors Defendant Over Design Defect Claim

NY Judges Favors Defendant Over Design Defect Claim

Introduction

In an order issued on September 29, 2018, Judge Alison Nathan of the U.S. District Court for the Southern District of New York, tossed a lawsuit filed against C.R. Bard's IVC filter design defects.

The plaintiff was implanted with Bard's IVC filter on October 30, 2002, which proved to be a failure later, as he suffered severe injuries due to device breakage and tissue perforation. The case was dismissed since the plaintiff failed to present the product's flaws and did not furnish a feasible alternative design; he was also unable to prove that the failure-to-warn claims made by BSC were insufficient.

The manufacturer faces more than 3,800 lawsuits following reports of design defects, device breakage, and tissue perforation. Multidistrict litigation (MDL No. 2641; In Re: Bard IVC Filters Products Liability Litigation) was created on August 17, 2015, in the United States District Court District of Arizona, presided over by Judge David G. Campbell for centralized pretrial proceedings.

Recently, the Arizona federal judge trimmed claims made by a plaintiff involved in the lawsuit stating that the plaintiff cannot be awarded for the possibility of a heart arrhythmia condition likely to take place in the future. This was the third C.R. Bard bellwether trial over the alleged injuries caused by Bard’s IVC filters.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!